Rationale and design of a randomized trial on the effectiveness of aerobic interval training in patients with coronary artery disease: The SAINTEX-CAD study

被引:16
|
作者
Conraads, Viviane M. [1 ,2 ]
Van Craenenbroeck, Emeline M. [1 ,2 ]
Pattyn, Nele [3 ,4 ]
Cornelissen, Veronique A. [3 ,4 ]
Beckers, Paul J. [1 ,2 ]
Coeckelberghs, Ellen [3 ,4 ]
De Maeyer, Catherine [1 ,2 ]
Denollet, Johan [1 ,5 ]
Frederix, Geert [1 ]
Goetschalckx, Kaatje [3 ,4 ]
Hoymans, Vicky Y. [1 ,2 ]
Possemiers, Nadine [1 ]
Schepers, Dirk [3 ,4 ]
Shivalkar, Bharati [1 ,2 ]
Vanhees, Luc [3 ,4 ]
机构
[1] Univ Antwerp Hosp, Dept Cardiol, B-2650 Edegem, Belgium
[2] Univ Antwerp, B-2020 Antwerp, Belgium
[3] Katholieke Univ Leuven Hosp, Louvain, Belgium
[4] Katholieke Univ Leuven, Dept Rehabil Sci, Res Ctr Cardiovasc & Resp Rehabil, B-3001 Heverlee, Belgium
[5] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands
关键词
Exercise intensity; Exercise training; Coronary artery disease; Secondary prevention; Cardiac rehabilitation; PEAK EXERCISE CAPACITY; CARDIAC REHABILITATION; HEART-DISEASE; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; EUROPEAN ASSOCIATION; MORTALITY; PREVENTION; STATEMENT; DISTRESS;
D O I
10.1016/j.ijcard.2013.05.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exercise-based cardiac rehabilitation is considered an important adjunct treatment and secondary prevention measure in patients with coronary artery disease (CAD). However, the issues of training modality and exercise intensity for CAD patients remain controversial. Objective: Main aim of the present study is to test the hypothesis that aerobic interval training (AIT) yields a larger gain in peak aerobic capacity (peakVO(2)) compared to a similar training programme of moderate continuous training (MCT) in CAD patients. Study design: In this multicentre study stable CAD patients with left ventricular ejection fraction > 40% will be randomized after recent myocardial infarction or revascularization (PCI or CABG) to a supervised 12-week programme of three weekly sessions of either AIT (85-90% of peak oxygen uptake [peakVO(2)], 90-95% of peak heart rate) or MCT (60-70% of peakVO2, 65-75% of peak heart rate). The primary endpoint of the study is the change of peakVO(2) after 12 weeks training. Secondary endpoints include safety, changes in peripheral endothelial vascular function, the evolution of traditional cardiovascular risk factors, quality of life and the number and function of circulating endothelial progenitor cells as well as endothelial microparticles. Possible differences in terms of long-term adherence to prescribed exercise regimens will be assessed by regular physical activity questionnaires, accelerometry and reassessment of peakVO(2) 12 months after randomization. A total number of 200 patients will be randomized in a 1: 1 manner (significance level of 0.05 and statistical power of 0.90). Enrolment started December 2010; last enrolment is expected for February 2013. (C) 2013 Published by Elsevier Ireland Ltd.
引用
收藏
页码:3532 / 3536
页数:5
相关论文
共 50 条
  • [41] Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing the effect of evolocumab on coronary microvascular function after percutaneous coronary intervention in patients with stable coronary artery disease
    Asakura, Masanori
    Hibi, Kiyoshi
    Shimizu, Wataru
    Fujii, Kenshi
    Suwa, Satoru
    Okumura, Yasuo
    Mano, Toshiaki
    Igeta, Masataka
    Okamoto, Rika
    Ishihara, Masaharu
    JOURNAL OF CARDIOLOGY, 2022, 79 (01) : 105 - 109
  • [42] Equity in Modifying Plaque of Women With Undertreated Calcified Coronary Artery Disease: The EMPOWER CAD Study Design and Rationale
    Lansky, Alexandra J.
    McEntegart, Margaret B.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (04) : S4 - S4
  • [43] THE EFFECT OF INTENSE AEROBIC CIRCUIT TRAINING IN CORONARY-ARTERY DISEASE (CAD) PATIENTS FOLLOWING CORONARY-ARTERY BYPASS-SURGERY (CABS)
    BRUCKERHOFF, D
    LAFONTAINE, T
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1984, 16 (02): : 127 - 128
  • [44] Rationale and design of a trial to personalize risk assessment in familial coronary artery disease
    Marwick, Thomas H.
    Whitmore, Kristyn
    Nicholls, Stephen J.
    Stanton, Tony
    Mitchell, Geoffrey
    Tonkin, Andrew
    Blizzard, Christopher
    Neil, Amanda
    Jones, Catherine
    Watts, Gerald F.
    AMERICAN HEART JOURNAL, 2018, 199 : 22 - 30
  • [45] Effectiveness of Aerobic, Resistance, and Combined Training for Hypertensive Patients: A Randomized Controlled Trial
    Alemayehu, Addis
    Teferi, Getu
    ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2023, 33 (06) : 1063 - 1074
  • [46] Study rationale and design of a study of EMPAgliflozin's effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial
    Gohari, Sepehr
    Reshadmanesh, Tara
    Khodabandehloo, Hadi
    Fathi, Mojtaba
    Ahangar, Hassan
    Arsang-Jang, Shahram
    Ismail-Beigi, Faramarz
    Ghanbari, Samin
    Dadashi, Mohsen
    Muhammadi, Muhammad Javad
    Gohari, Sheida
    Ghaffari, Saeid
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [47] Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial
    Sepehr Gohari
    Tara Reshadmanesh
    Hadi Khodabandehloo
    Mojtaba Fathi
    Hassan Ahangar
    Shahram Arsang-Jang
    Faramarz Ismail-Beigi
    Samin Ghanbari
    Mohsen Dadashi
    Muhammad Javad Muhammadi
    Sheida Gohari
    Saeid Ghaffari
    BMC Cardiovascular Disorders, 21
  • [48] Aerobic interval versus continuous training in coronary artery disease and chronic heart failure patients: an updated meta-analysis of randomized clinical trials
    Pattyn, N.
    Beulque, R.
    Cornelissen, V.
    EUROPEAN HEART JOURNAL, 2017, 38 : 518 - 518
  • [49] PERindopril—Function of the Endothelium in Coronary Artery Disease Trial: The PERFECT Study—Sub Study of EUROPA: Rationale and Design
    Michiel L. Bots
    Willem J. Remme
    Tomas F. Lüscher
    Diederick E. Grobbee
    Cardiovascular Drugs and Therapy, 2002, 16 : 227 - 236
  • [50] PERindopril -: Function of the endothelium in coronary artery disease trial:: The PERFECT study -: Sub study of EUROPA:: Rationale and design
    Bots, ML
    Remme, WJ
    Lüscher, TF
    Grobbee, DE
    CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (03) : 227 - 236